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ABSTRACT 
BACKGROUND:  Many patients experience pain on injection of propofol. The use 
of lidocaine to prevent propofol injection pain is common. The analgesic effect of pre- 
injected lidocaine has been found to increase when a tourniquet is used. 
OBJECT IVE:  The aim of this study was to compare the effectiveness of vari- 
ous venous occlusion times with lidocaine analgesia to prevent pain during propofol 
injection. 
METHODS:  In this prospective, randomized, ouble-blind, controlled study, wom- 
en aged 18 to 45 years, classifed as American Society of Anesthesiologists physical sta- 
tus I or II, who were scheduled to undergo elective surgery under general anesthesia n- 
duced with propofol, were randomly assigned to 1 of 5 groups: group 1, 2% lidocaine 
20 mg in saline in a total volume of 10 mL and no venous occlusion; group 2, 2% lido- 
caine 20 mg in saline in a total volume of 10 mL plus venous occlusion for 15 seconds; 
group 3, 2% lidocaine plus venous occlusion for 30 seconds; group 4, 2% lidocaine plus 
venous occlusion for 60 seconds; and group 5, saline 10 mL and no venous occlusion. 
When the first 25% of the calculated propofol dose was administered, patients were 
asked about propofol-induced pain using a verbal pain scale (0 no pain; 1 mild 
pain; 2 moderate pain; and 3 severe pain). All patients and the anesthesiologist who 
evaluated pain severity were blinded to the study preparation being used. 
RESULTS:  The study comprised 100 women who were randomly divided into 
5 groups of 20 patients each. Significantly more patients in group 5 (18 [90%] patients; 
P < 0.05) reported pain compared with the other treatment groups. In groups 2, 3, and 
4, in which venous occlusion was applied, pain was reported uring propofol injection 
in 6 (30%), 7 (35%), and 2 (10%) patients, respectively. The incidence of reported pain 
was significantly greater in group 1 (lidocaine without venous occlusion) than in group 4 
(P < 0.05); however, the incidence of pain was similar in group 1 compared with 
groups 2 and 3. 
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CONCLUSIONS:  The present study found that pretreatment with lidocaine 
20 mg with or without venous occlusion significantly reduced the incidence and the 
severity of pain during the injection of propofol when compared with the group with 
no venous occlusion administered saline. In addition, pretreatment with lidocaine 
20 mg plus venous occlusion for 60 seconds significantly reduced the incidence of 
propofol-induced pain compared with lidocaine without venous occlusion. (Curt Ther 
Res C/in Exp. 2008;69:29 35) © 2008 Excerpta Medica Inc. 
KEY WORDS:  intravenous anesthetic, propofol, complication, pain, local anes- 
thetic, lidocaine, venous occlusion. 
INTRODUCTION 
Propofol is widely used for induction of general anesthesia because of its fast action and 
recovery characteristics. 1 However, many patients experience pain on injection of this 
agent, and pain occurs in up to 100% of patients if a vein on the dorsum of the hand 
is used. 2 Several methods have been proposed to reduce the pain associated with IV 
administration ofpropofol. These include the addition of lignocaine to propofol3; cool- 
ing or warming the drug4; pretreatment with ephedrine, ondansetron, metoclopramide, 
opioids, thiopental, ketamine, 5 ketorolac, 6 nafamostat mesylate, 7 or acetaminophen. 8 
In a recent study, 9 small doses of different formulas of propofol that included long- 
chain triglycerides (LCT) alone and medium-chain triglycerides (MCT) with LCT were 
preadministered. They found that preinjection of LCT propofol was more effective in 
preventing pain than LCT/MCT propofol. 9 
The use of lidocaine to prevent propofol injection pain has been extensively studied 
and is a common method used in clinical practice. > Picard and Tram~r 5 conducted a 
meta-analysis of 56 studies evaluating prevention of pain on injection of propofol and 
concluded that lidocaine should be administered with a rubber tourniquet before the 
propofol injection for the most effective pain prevention. It is presumed that preinjected 
lidocaine acts mostly as a local anesthetic. Sasaki et al ll noted that the analgesic effect 
of preinjected lidocaine increased when a tourniquet was used concomitantly. A search 
of MEDLINE (1990 Present), using the terms pain, injection, propofol, venous occlusion, 
lidocaine, and duration, found limited data comparing the duration of venous occlusion 
needed for lidocaine to have a peripheral analgesic effect as a result of local anesthetic 
activity. 12 The most appropriate duration of venous occlusion in this situation eeds to 
be determined. 
The aim of this study was to compare the effectiveness of various venous occlusion 
times for lidocaine analgesia to prevent pain during propofol injection. 
PAT IENTS AND METHODS 
After approval was obtained from the local ethics committee and written informed 
consent was obtained from the patients, women classified as American Society of 
Anesthesiologists physical status I or 11,12 who were aged 18 to 45 years, and who were to 
undergo elective gynecologic laparoscopic surgery under general anesthesia at the Dicle 
University Hospital, Diyarbakir, Turkey, were recruited into this prospective, random- 
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ized, double-blind, controlled study. Patients were excluded if they had any difficulty 
communicating, were uncooperative, had chronic pain, had received any type of analge- 
sia at the site of IV cannula insertion before arriving in the operating room (including 
EMLA cream [AstraZeneca LP, Wilmington, Delaware], which contains lidocaine 2.5% 
and prilocaine 2.5%), or had a hypersensitivity reaction to anesthetic agents. 
Five anesthesiologists were involved in the study in 3 steps. The first step involved 
one of the anesthesiologists (S.K. or S.O.) preparing identical syringes of saline or the 
study drug prior to randomization; the anesthesiologist then left the room. In the second 
step, a second anesthesiologist (S.T. or H.K.) performed venous occlusion with a tour- 
niquet. For the last step, the anesthesiologist (N.B.), who evaluated pain severity during 
propofol injection, and the patients were blinded to the study preparation being used. 
As preanesthetic medication, all patients received 150 mg of ranitidine orally 
120 minutes before induction of anesthesia. On arrival in the operating room, a 
20-G IV cannula was inserted into the dorsum of the nondominant hand and attached 
to the Ringer's solution; routine monitoring was then started. Patients were randomly 
assigned by computer to 1 of 5 groups: group 1, 2% lidocaine 20 mg in saline in a 
total volume of 10 mL and no venous occlusion; group 2, 2% lidocaine 20 mg in 
saline in a total volume of 10 mL plus venous occlusion for 15 seconds; group 3, 2% 
lidocaine plus venous occlusion for 30 seconds; group 4, 2% lidocaine plus venous 
occlusion for 60 seconds; and group 5 (control), saline 10 mL and no venous occlu- 
sion. The durations of tourniquet application were the same as in the study by Ewart 
and Whitwam. 12 
Venous occlusion was performed with a rubber tourniquet applied to the forearm 
-10 cm distal to the elbow joint, which was thought o be high enough to prevent free 
flow of Ringer's solution. Sham venous occlusion in groups 1 and 5 was achieved using 
a rubber tourniquet that did not prevent he free flow of Ringer's solution. The line of 
Ringer's solution was closed in all groups after the rubber tourniquet was applied, and 
the study drug was injected over 10 seconds. The anesthesiologist responsible for the 
tourniquet after administration of the study drug attached the propofol injector to the 
vein route and then called a second anesthesiologist, whose responsibility was to carry 
out the injection in the operating room, and instructed the latter to start the propofol 
injection when appropriate. 
After 25 % of the calculated propofol dose of 2 mg/kg was administered (injection 
rate, -1200 mL/h), the patients were asked about propofol-induced pain by an an- 
esthesiologist (N.B.), who was blinded to the patients' group assignments, using a 
4-point verbal pain scale (0 no pain; 1 mild pain; 2 moderate pain; and 3 severe 
pain). Thereafter, the remainder of the propofol dose was administered. Rocuronium 
0.6 mg/kg was administered intravenously for muscle relaxation and to facilitate tra- 
cheal intubation, and anesthesia was maintained using sevoflurane and nitrous oxide. 
STAT IST ICAL  ANALYS IS  
In the study by Fujii and Nakayama, 13the incidence of pain during propofol injec- 
tion after 1 minute of manual venous occlusion was reported to be 40% in the group 
administered lidocaine 20 mg. In our study, the sample size calculation was based on a 
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power analysis for reducing the incidence of pain from 40% to 5%. At a power of 0.8, 
using a significance l vel o fP  < 0.05, the sample size required was 20 subjects/group. 
Data were analyzed using 1-way analysis of variance and the Kruskal-Wallis test. 
Data were expressed as mean (SD) or number (proportion), as appropriate. P < 0.05 was 
considered statistically significant. Statistical analysis was performed using SPSS for 
Windows, release 9.0, standard version (SPSS Inc., Chicago, Illinois). 
RESULTS 
The study comprised 100 women (mean [SD] age, 30.9 [7.5] years; weight, 63.9 [10.6] kg) 
who were randomly divided into 5 groups of 20 patients each; the 5 groups were similar 
in terms of demographic characteristics (Table). 
The incidence of pain due to propofol injection in each group is shown in the table. 
Significantly more patients in group 5 (18 [90%] patients; P < 0.05) reported pain com- 
pared with the other treatment groups (group 1, 9 [45%] patients; group 2, 6 [30%]; 
group 3, 7 [35%]; group 4, 2 [10%]). In addition, significantly more patients in group 1 
reported propofol-induced pain compared with group 4 (P < 0.05). There was no sig- 
nificant difference in the incidence of pain between group 4 and groups 2 or 3. 
The severity of pain was significantly higher in group 5 (median pain score 2) com- 
pared with the other 4 groups (all, median pain score 0; P < 0.05). No statistically 
Table. Demographic and clinical characteristics of study patients receiving propofol 
injection (N = 100). 
Variable 
Group 2 Group 3 Group 4 
Group 1 (Lidocaine + (Lidocaine + (Lidocaine + Group 5 
(Lidocaine) VO 15 s) VO 30 s) VO 60 s) (Saline) 
(n = 20) (n = 20) (n = 20) (n = 20) (n = 20) 
Age, mean (SD), y 33.1 (8.8) 30.8 (6.0) 30.8 (7.3) 32.2 (9.3) 27.7 (6.1) 
Weight, mean (SD), 
kg 67.5 (11.1) 62.2 (12.3) 63.6 (13.8) 63.4 (8.0) 62.7 (7.9) 
Patients with pain, 
no. (%) 9 (45)*t 6 (30)t 7 (35)t 2 (lO)t 18 (90) 
Pain scale score,¢ 
median (range) Ot (0-1) Ot (0-1) Ot (0-2) Ot (0-1) 2 (0-3) 
Grading of pain, 
no. (%) 
No 11 (55) 14 (70) 13 (65) 18 (90) 2 (10) 
Mild 9 (45) 6 (30) 6 (30) 2 (10) 3 (15) 
Moderate 0 0 1 (5) 0 6 (30) 
Severe 0 0 0 0 9 (45) 
VO = venous occlusion. 
*P < 0.05 versus group 4. 
tp < 0.05 versus group 5. 
¢Scale: 0 = no pain; $ = mild pain; 2 = moderate pain; 3 = severe pain. 
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significant differences were observed between groups 1, 2, 3, and 4 in the severity 
of pain. 
DISCUSSION 
In our study, the incidence and severity of pain were significantly less in the lidocaine 
groups with and without venous occlusion compared with the control group. The inci- 
dence of pain on injection ofpropofol after saline was 90%. In the groups with lidocaine 
pretreatment without venous occlusion and with venous occlusion for 15 seconds and 
for 30 seconds, pain on injection of propofol was not entirely controlled. The reported 
failure rate was between 30% and 45%. However, in group 4 (venous occlusion for 
60 seconds), propofol-induced pain was reported by 10% of patients; this difference was 
significantly greater than in group 1 (lidocaine without venous occlusion) (P < 0.05), 
but was similar to the incidence of pain in the other 2 groups with venous occlusion 
(groups 2 and 3). The severity of reported pain was significantly milder in the lidocaine 
pretreatment groups than the control group (all, P < 0.05). 
Pain on propofol injection is a common problem and can be distressing to the 
patient. The reported incidence of pain varies between 28% and 90% in adults during 
induction of anesthesia and may be severe, l° The cause of pain on propofol injection is 
not known, although there are several proposed mechanisms. Triggering of the kinin 
cascade, stimulation of the nociceptive receptors at the free nerve endings located 
between the intima and the media layers of the venous wall, and the effect of propo- 
fol pH and concentration are all considered possible mechanisms of propofol-induced 
pain. l° Preinjected lidocaine is thought o act mostly as a local anesthetic. It has been 
suggested that lidocaine is not effective in reducing the pain of propofol injection, 
except when a tourniquet is used. ll The mechanism of action is possibly the blockade 
of the nerve fibers responsible for pain transmission resulting from direct irritation of 
the inner walls of blood vessels by propofol; this direct anesthetic effect of lidocaine is 
achieved when sufficient ime is allowed for the drug to work. 14 However, the results of 
studies related to the amount of time lidocaine remains in blood vessels when a tourni- 
quet is used are controversial. 12 Local anesthetic activity of lidocaine may be high due to 
long duration, but in the study of Ewart and Whitwam, 12 lidocaine was most effective 
at reducing pain when administered immediately before applying propofol. 
Liaw et a115 found that IV lidocaine was retained in the veins for 1 minute, and 
injecting propofol after releasing the rubber tourniquet was found to be effective in 
reducing pain when compared with the saline group. In this study, 3 different ech- 
niques for reducing propofol injection pain with metoclopramide w re compared with 
lidocaine or saline to evaluate the most effective method in reducing propofol 
injection pain. 15 The study differed from ours in that lidocaine 40 mg was used; 
we used lidocaine 20 rag. Liaw et al found the incidence of pain to be 11% in 
35 patients. Ewart and Whitwam 12 found that the incidence of pain increased as the 
time increased between the injection of lidocaine and propofol, based on observing 
5 randomly selected groups of 20 unpremeditated patients cheduled for minor gyne- 
cologic surgery. A tourniquet was applied to the proximal part of the forearm and a 
23-G cannula was placed in a vein in the dorsum of the hand. In the control group, 
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the tourniquet was released; in the other groups, lidocaine was injected, producing a 
"mini-Bier block." After intervals of 10, 30, 60, or 90 seconds, the tourniquet was 
released and propofol was administered. Pain was significantly reduced in the groups 
to which lidocaine was administered after 10 or 30 seconds of venous occlusion before 
propofol administration (P < 0.05 and P < 0.01, respectively). The authors uggested 
that lidocaine was most eftective in reducing pain when administered immediately 
before propofol injection and that there was no difterence in the frequency of pain after 
injections of propofol between groups with venous occlusion for 60 and 90 seconds 
and the control group. 12 
Venous occlusion was carried out with a rubber tourniquet for 2 minutes in a study 
by Fujii and Nakayama. 2 They used 2% lidocaine 20 mg and added 0.9% normal saline 
to make a total volume of 6 mL. The authors found that lidocaine pretreatment with 
venous occlusion for 2 minutes significantly reduced the incidence of propofol-induced 
pain from 90% to 27% (P < 0.01). In another study by Fujii and Nakayama, 13a rubber 
tourniquet was applied for venous occlusion and 1% lidocaine 20 mg was administered 
with saline to make a total volume of 2 mL. After 1 minute, the tourniquet was released 
and propofol was injected. This study found that lidocaine 20 mg with venous occlu- 
sion for 1 minute prevented pain on propofol injection in 12 of 30 patients (40%). The 
findings in our study were not comparable to the findings of these studies. We think 
that the higher total volume used in our study (10 mL) increased the distribution of 
the drug, leading to a good local anesthetic eftect that varied with the residence time 
of the drug. 
When the local anesthetic was administered intravenously after venous occlusion 
using the rubber tourniquet method, the total volume of the drug dose aftected rug 
distribution. Although the dose of lidocaine used in these studies was the same dose 
we used, the total volume administered was lower than the volume we used. Lidocaine 
has been used most frequently for regional IV anesthesia t concentrations of 0.25% 
to 0.5%. 16 In our study, lidocaine was used as 20 mg (2% mL) in a total of 10 mL of 
solution (0.2%), resulting in better distribution and greater analgesia from lidocaine 
during venous occlusion. Lidocaine 20 mg plus venous occlusion of varying durations 
was associated with a significantly greater eduction in propofol-induced pain compared 
with the lidocaine without venous occlusion group and the saline group. This eftect 
might have been due to the higher total volume of the injected solution than that in 
the other studies mentioned above. 
One challenging factor was the difficulty ensuring that the study was randomized 
and double-blind with regard to tourniquet application. The anesthesiologist who evalu- 
ated the patients was kept waiting outside of the operating room during the preparation 
stage, so that he was blinded to whether or not venous occlusion was performed. The 
anesthesiologist who prepared the study drug left the operating room during the other 
stages of the study so that the anesthesiologist performing the venous occlusion did not 
know whether the drug being administered was saline or lidocaine. In addition, the 
patients did not know which drugs they were receiving or whether or not the tourniquet 
was a sham. When all of these procedures are taken into consideration, we believe that 
we were able to ensure the study was randomized and double-blind. 
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CONCLUSIONS 
The present study found that pretreatment with lidocaine 20 mg with or without 
venous occlusion significantly reduced the incidence and the severity of pain during 
the injection of propofol when compared with the control group administered saline 
without venous occlusion. In addition, the incidence of pain was significantly lower in 
the group administered lidocaine plus venous occlusion for 60 seconds compared with 
the group administered lidocaine without venous occlusion. 
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